GREP: genome for REPositioning drugs.
Level V
Where this comes from
- Record sourced from PubMed, PMID 30859178.
- Also identified by DOI 10.1093/bioinformatics/btz166 and PMC identifier 6761931.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Making use of accumulated genetic knowledge for clinical practice is our next goal in human genetics. Here we introduce GREP (Genome for REPositioning drugs), a standalone python software to quantify an enrichment of the user-defined set of genes in the target of clinical indication categories and to capture potentially repositionable drugs targeting the gene set. We show that genes identified by the large-scale genome-wide association studies were robustly enriched in the approved drugs to treat the trait of interest. This enrichment analysis was also highly applicable to other sets of biological genes such as those identified by gene expression studies and genes somatically mutated in cancers. This software should accelerate investigators to reposition drugs to other indications with the guidance of known genomics. GREP is available at https://github.com/saorisakaue/GREP as a python source code. Supplementary data are available at Bioinformatics online.
Medical subject headings
- Drug Repositioning
- Genome
- Genome-Wide Association Study